Archive · 25 Jun 2025
Malaria Vaccine Price to Drop Under $5 by 2028
Imagine a shot that helps protect kids from getting sick with malaria.
Two companies, Bharat Biotech and GSK, are making this shot cheaper.
They're aiming to lower the price to under $5 so more kids in places where malaria is common can get it.
They're doing this by making the shots in a better way and making lots of them.
The shot is already being used in some African countries, and by 2025, even more kids will be able to get it.
It is supported by organizations like the WHO and Gavi to help kids stay healthy.
Bharat Biotech and GSK will reduce the price of the world's first malaria vaccine, RTS,S, to under $5 by 2028.
This initiative aims to improve accessibility for millions of people in malaria-endemic countries.
The price reduction is part of a pledge to the Gavi Vaccine Alliance for its 2026-2030 phase.
The reduction is due to improvements in manufacturing and increased production capacity.
The vaccine is expected to be added to daily immunizations in 12 African countries by the end of 2025.
- Who
- Bharat Biotech and GSK, with support from WHO, PATH, and Gavi, among others.
- What
- Bharat Biotech and GSK are reducing the price of the RTS,S malaria vaccine.
- When
- The price reduction is expected to be implemented by 2028.
- Where
- Malaria-endemic countries
- Why
- To improve accessibility and help protect children at risk of malaria.
- Vaccine Name
- RTS,S
- Price Reduction
- Under $5
- Target Year
- 2028
- Companies Involved
- Bharat Biotech and GSK
- Supported by
- WHO, PATH, Gavi, etc.
- Geographic Focus
- Malaria-endemic countries